Staff editor
Pilar Manrique Ronquillo, Research Scientist at Microviable Therapeuthics, talks about the donor-based microbiome therapeutic products research and development.
MaaT033 (capsule), which is being developed as an adjunctive and maintenance therapy to improve overall survival in allo-HSCT, has received orphan drug designation (ODD) status from the European Medicines Agency…
New Study Demonstrates Positive Effects of NORDBIOTIC Probiotic Strains on Irritable Bowel Syndrome (IBS) in Adult Patient.
Elisa Cirillo, team lead research data manager at The Hyve, talks about the importance of having high quality data and strong tools to improve the microbiome research and business.
Industry
Sponsored by
A new scientific publication on the antimicrobial, antiadhesive and co-aggregation activity against different urogenital pathogens.
Jeroen Raes, from KU Leuven, Belgium, talks about the design of clinical trials for IBD patient with microbiome based therapies.
Lihi Godny, from Rabin Medical Center in Israel, talks about the next steps research has to focus in to improve the FMT efficacy for IBD patients.
According to the authors, results suggest that patients with a specific microbial signature have a more favorable response to therapy.
Pedro Correa de Sampaio, Chief Executive Officer at Neobe Therapeutics, talks about the challenges to remove immunosuppressive constraints that prevent the infiltration of immune cells in a subset of cancers.
Industry
Sponsored by
In a newly published study Probi´s proprietary strain L. plantarum HEAL9 (HEAL9™) was shown to significantly improve cognitive performance.
